retatrutide triple agonist glp-1 gip glucagon phase 2 obesity Dual and Gut Peptide Agonists on the Horizon for the Treatment of Type Diabetes and Obesity. An Overview of Preclinical and Clinical Data | Current Reports ADA 2026: Retatrutide Revolution

Glucagon-like peptide-1 (GLP-1) is an incretin hormone, one of several gut-derived peptides secreted in response to nutrient intake that promote insulin release

These improvements could significantly enhance adherence and quality of life for patients managing chronic conditions like diabetes

Under this plan, Medicare recipients are expected to be covered for GLP-1s, with a $50 monthly cap on patient out-of-pocket spending

The clinical team at JosephCareRX is available to discuss whether GLP-1 receptor agonists like Ozempic are appropriate for your individual health goals and needs

Human glucagon-like peptides 1 and 2 activate rat brain adenylate cyclase